Peter Greb

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Boehringer Ingelheim (Austria)13.3%
• University of Dundee12.3%
• Dana-Farber Cancer Institute10.6%
• Harvard University10.4%
• University of Michigan8.4%
• AstraZeneca (United Kingdom)6.5%
• Other38.4%

Fields

• Biochemistry, Genetics and Molecular Biology80.2%
• Medicine12.2%
• Computer Science3.9%
• Chemistry1.8%
• Immunology and Microbiology1%
• Materials Science0.2%
• Other0.6%

Topics

• Protein Degradation and Inhibitors27.8%
• Ubiquitin and proteasome pathways21.8%
• Peptidase Inhibition and Analysis11.7%
• Multiple Myeloma Research and Treatments6.9%
• Protein Kinase Regulation and GTPase Signaling5.1%
• Histone Deacetylase Inhibitors Research4.4%
• Other22.3%